Introducing the new Coblation™ Turbinator™ turbinate reduction wand: Our initial experience of twenty-two patients requiring surgery for nasal obstruction

Abstract

Coblation^™ Turbinator^™ is a coblation wand designed specifically for turbinate reduction surgery.

We present an audit of 22 patients evaluating the clinical outcome of septoturbinoplasty for nasal obstruction caused by inferior turbinate hypertrophy using the Coblation^™ Turbinator^™ wand and comparing it to a similar-sized cohort who had microdebrider turbinoplasty.

Primary clinical outcome was evaluated using the Nasal Obstruction Symptom Evaluation (NOSE) scale and the peak nasal inspiratory flow rate measurement and secondary outcome measures were days of admission or readmission rates and episodes of bleeding.

There was improvement in both primary clinical outcome measures for the Coblation^™ Turbinator^™ and this was comparable to the microdebrider with no complications.

This is the first report of clinical outcomes using the Coblation^™ Turbinator^™ for septoturbinoplasty and further long-term studies are required to assess the reproducibility of the data reported here.

This article is protected by copyright. All rights reserved.

http://ift.tt/2gZ9bPM